SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MMJ GROUP HOLDINGS LIMITED (MMJ)

Listed on ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
MMJ GROUP HOLDINGS LIMITED23/10/2018
MMJ PHYTOTECH LIMITED31/07/201523/10/2018
PHYTOTECH MEDICAL LIMITED31/07/2015

Shareholder links

Our website ranking of MMJ: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MMJ4
Address: Suite 518, Level 5, 165-167 Phillip Street, Sydney NSW 2000
Tel:  +61 2 8098 0819 Fax: +61 2 8080 8315

Date first listed: 22/01/2015
Company Secretary: Jim Hallam
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Listed Investment Company

The suspension of trading in the securities of MMJ Group Holdings Ltd ("˜MMJ') will be lifted immediately, following the release by MMJ of an announcement regarding its suspension and planned share purchase plan

19/12/2018

The company notes that its shares were placed into suspension by the Australian Securities Exchange ("ASX") on 13 December 2018 pending the result of further enquiries by the ASX regarding MMJ's cash position and capital raising intentions.

19/12/2018

The company's net tangible assets per share as at 30 November 2018 was 22.34 cents (pre-tax) and 21.32 cents (post-tax).

14/12/2018

The securities of MMJ Group Holdings Limited will be suspended from quotation immediately under Listing Rule 17.3, pending response to ASX queries.

12/12/2018

The suspension of trading in the securities of MMJ Group Holdings Limited will be lifted from the commencement of trading tomorrow, Thursday, 22 November 2018.

21/11/2018

The securities of MMJ Group Holdings Limited were reinstated to official quotation today in error. All trades today in the securities of MMJ will be cancelled and the order book purged. Trading in the securities of MMJ will resume from the commencement of trading tomorrow, Thursday, 22 November 2018.

21/11/2018

The securities of MMJ Group Holdings Limited will be reinstated to Official Quotation at the commencement of trading at 10:04:30am AEDT (+/- 15 seconds) as part of Group 3 on Thursday, 22 November 2018, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules.

20/11/2018

MediPharm Labs Inc has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc.

15/11/2018

Harvest One Cannabis has entered into a multi-year cannabis extraction services agreement with Valens GroWorks Corp. MMJ owns 47.7 million shares in Harvest One for an approximate 27% shareholding.

15/11/2018

MediPharm Labs has been issued a sales licence by Health Canada. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

13/11/2018

The company has invested CAD$2.5 million of equity into privately-held Embark Health Inc. This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%.

12/11/2018

The company has made a cornerstone equity investment of USD$1 million for an 18.2% shareholding in privately-held VitaGenne Inc.

08/11/2018

The company releases a copy of the news release by MediPharm Labs confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

08/11/2018

The company releases an announcement confirming that Fire & Flower Inc. has raised CAD$36.5 million, above its original target of CAD$30 million, from equity instruments ahead of its proposed listing on the TSX Venture Exchange.

05/11/2018

The company has lodged a notice with the TSX Venture Exchange stating its intention to divest up to 5 million of its 48.333 million* shares held in Harvest One Cannabis.

01/11/2018

The company releases a notice of AGM. The meeting will be held at 2:30pm (AEDT) on Wednesday 28 November 2018 at The Westin Sydney 1 Martin Place Sydney, NSW 2000 Australia.

29/10/2018

The company lodges its Annual Report to shareholders.

29/10/2018

The company releases a copy of the management discussion and analysis for the financial year ended 30 June 2018 recently released by Harvest One Cannabis Inc.

29/10/2018

The company lodges its Appendix 4C - quarterly.

29/10/2018

The company has divested 5 million of its 53.333 million shares held in Harvest One Cannabis Inc. through an on-market sale. The intention to make this divestment was first announced by MMJ on 12 October 2018. Including the proceeds of this divestment, MMJ's unaudited corporate cash balance is approximately AUD$5.6 million. MMJ now owns 48.333 million* shares in Harvest One for an approximate 28% shareholding.

26/10/2018

The company releases an announcement by Bod Australia Limited confirming that they have entered into a collaboration agreement with Cannabis Access Clinics. MMJ has AUD$1 million invested in Cannabis Access Clinics for a 17.4% shareholding.

25/10/2018

The company releases an announcement by Harvest One Cannabis Inc confirming the appointment of Will Stewart as its Senior Vice President, Corporate and Public Affairs. MMJ is the largest single shareholder in Harvest One.

24/10/2018

The company releases MediPharm Labs' Management Presentation.

23/10/2018

name changed from MMJ Phytotech Limited

23/10/2018

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    24/04/2019Doug Halley63,000$0.235$14,804
    18/04/2019Doug Halley137,000$0.240$32,880
    11/10/2016Peter Wall100,000$0.230$23,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Peter WallNon Exec Chairman01/03/2012
    Catherine HarveyCOO01/09/2016
    Jim HallamCFO03/04/2018
    Winton WillesseNon Exec Director
    Doug HalleyNon Exec Director16/03/2018
    Michael CurtisNon Exec Director08/01/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Jason ConroyCEO26/02/201801/03/2019
    Lisa DeaCFO14/06/201703/04/2018
    Jason BednarNon Exec Director16/03/2018
    Andreas GedeonManaging Director, CEO27/07/201526/02/2018
    Richard JarvisCFO04/07/201614/06/2017
    Ross McKayNon Exec Director11/08/2016
    Benad GoldwasserNon Exec Director27/01/201520/08/2015
    Boaz WachtelExecutive Director20/08/2015
    Ross SmithDirector02/02/2015

    Date of first appointment, title may have changed.